BioDelivery Sciences International To Acquire US And Canadian Rights To ELYXYB From Dr. Reddy’s Laboratories For Upfront Payment Of $6M Plus An Additional $9M
The only FDA-approved, ready-to-use oral solution for the acute treatment of migraine with or without aura in adults
First step to building a growth platform in Neurology
Patent protection until 2036
RALEIGH, N.C.,
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs.
Dr. Reddy’s Lab, Fortress Biotech Ink DFD-29 Collaboration Pact For Chronic Skin Disorder
Journey Medical Corporation, a partner company of Fortress Biotech Inc (NASDAQ:FBIO), has entered into a collaborative development and commercialization agreement with Dr. Reddy’s…
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 21)
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 255 companies made new 52-week highs.
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 235 stocks hit new 52-week highs.
Dr Reddy’s Rolls Out Sputnik V COVID-19 Vaccine In India At $13.58/Dose
Dr. Reddy’s Laboratories Ltd (NYSE: RDY) said that it expects to get 36 million doses of Sputnik V COVID-19 vaccine in the…
Stocks That Hit 52-Week Highs On Wednesday
During the morning session on Wednesday, 398 stocks hit new 52-week highs. Interesting Highlights: Alphabet (NASDAQ:GOOGL) was the largest company…